ENHANCEMENT OF IMMUNE CHECKPOINT BLOCKADE RESPONSIVENESS AND TERTIARY LYMPHOID STRUCTURE FORMATION THROUGH CD4+TFHX13 CAR-T CELLS TO ACHIEVE CCRCC CURES.

Dana-Farber Cancer Institute, Inc.

Investigators